Latest AI and machine learning research in liver transplantation for healthcare professionals.
Metabolic dysfunction-associated steatohepatitis (MASH), the progressive inflammatory form of MASLD, is now a leading cause of chronic liver disease worldwide. Driven by obesity and type 2 diabetes, MASH significantly increases the risk of cirrhosis, hepatocellular carcinoma, and liver failure. While public health interventions remain essential, therapeutic strategies targeting metabolic dysfuncti...
Fungal secondary metabolites (SMs) represent a vast reservoir of bioactive compounds with immense therapeutic, agricultural, and industrial potential. These small molecules, including antibiotics, immunosuppressants, and anticancer agents, are synthesized through dedicated biosynthetic gene clusters (BGCs) regulated by various epigenetic, transcriptional, and environmental mechanisms. However, the...
Kidney transplantation (KT) remains the preferred treatment for end-stage renal disease. With advancements in immunosuppressive regimens and KT survei...
This study aimed to identify the risk factors associated with spontaneous rupture and bleeding in hepatocellular carcinoma, establish a prediction mod...
OBJECTIVE: To develop and validate a novel diagnostic model for detecting bacterial infections in patients with hepatitis B virus-related acute-on-chr...
Traditional methods for measuring body composition in CT scans rely on labor-intensive manual delineation, which is time-consuming and imprecise. This...
BACKGROUND: Acute graft-versus-host disease (aGVHD) is a major post-transplantation complication and one of the most significant causes of non-relapse...
Immune checkpoint blockade therapy has revolutionized clinical oncotherapy by intercepting immunosuppressive pathways in tumor tissues. Nevertheless, ...
Medical predictions, for example, concerning a patient's likelihood of survival, can be used to efficiently allocate scarce resources. Predictions of ...
Electronic health record (EHR)-based models to identify individuals who may benefit from pre-exposure prophylaxis (PrEP) outperform traditional risk s...
PURPOSE: Early-stage cirrhosis frequently presents without symptoms, making timely identification of high-risk patients challenging. We aimed to devel...
Around 1.5 million new cases of Hepatitis C Virus (HCV) are diagnosed globally each year (World Health Organization, 2023). Consequently, there is a p...
The early detection of liver cirrhosis and its complications is a conundrum in clinical practice. We aim to address this conundrum using proteomic fea...
Artificial Intelligence (AI) offers a revolutionary approach to improve decision-making in medicine through the use of advanced computational tools. I...
OBJECTIVE: Hepatitis B virus (HBV) is a significant global health threat, responsible for severe liver diseases such as liver failure, cirrhosis, and ...
Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by its lack of estrogen, progesterone, and HER2 receptors, leading to limi...
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a spectrum of chronic pathologic conditions strongly associated with metabolic syn...
BACKGROUND: Epidemiological studies on idiopathic nephrotic syndrome (INS) in children have identified no definitive factors predicting steroid-resist...
To develop and validate a machine learning prediction model for 28-day all-cause mortality in patients with alcoholic cirrhosis using data from the MI...
Breast cancer (BC) is a heterogeneous disease with diverse subtypes that influence prognosis and treatment outcomes. While advances have been made in ...